3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
10
Breast Neoplasms
9
Colonic Neoplasms
6
Carcinoma, Non-Small-Cell Lung
5
Rectal Neoplasms
4
Lung Neoplasms
4
Head and Neck Neoplasms
4
Adenomatous Polyposis Coli
4
Sarcoma
3
Glioblastoma
3
Central Nervous System Neoplasms
3
Paranasal Sinus Neoplasms
2
Neoplasms
2
Mouth Neoplasms
2
Melanoma
2
Laryngeal Neoplasms
2
Gliosarcoma
2
Breast Carcinoma In Situ
2
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Triple Negative Breast Neoplasms
1
Tobacco Use Disorder
1
Stomatitis
1
Smoldering Multiple Myeloma
1
Smoking
1
Recurrence
1
Prostatic Neoplasms
1
Prostatic Hyperplasia
1
Precancerous Conditions
1
Interventions
fludarabine phosphate
18
Whole-Body Irradiation
12
Peripheral Blood Stem Cell Transplantation
12
Mycophenolic Acid
11
ruxolitinib
10
Busulfan
10
Tacrolimus
9
Cyclophosphamide
9
fludarabine
6
Methotrexate
5
Melphalan
5
Cyclosporine
5
Hydroxyurea
4
Antilymphocyte Serum
4
pomalidomide
3
givinostat hydrochloride
3
givinostat
3
Stem Cell Transplantation
3
Prednisone
3
Lenalidomide
3
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
3
thymoglobulin
2
peginterferon alfa-2a
2
merphos
2
Surveys and Questionnaires
2
Radiotherapy
2
Imatinib Mesylate
2
Etoposide
2
Dasatinib
2
Carboplatin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Polycythemia Vera
×
Celecoxib
×
Clear all
No trials found.